Bayer (ETR:BAYN) has reportedly sold its Multi Vendor Service medical device repair business to private investors who plan to merge it with 2 other firms to form a new company based in Pittsburgh, Penn., according to a Pennsylvania Post-Gazette report. Bayer’s MVS provides service and repairs for radiology devices, covering ultrasound probes, magnetic resonance imaging coils […]
Bayer
Xarelto, aspirin combo reduces risk of cardiovascular events in pivotal Ph3 trial
Johnson & Johnson (NYSE:JNJ) subsidiary Janssen touted data today from a pivotal Phase III trial showing that Xarelto plus aspirin reduced the risk of major cardiovascular events in patients with stable coronary and peripheral artery disease compared to aspirin alone. Treatment with Xarelto twice per day and aspirin once-daily cut the risk of major cardiovascular events […]
House Dems launch MS drug pricing probe
Democrats from the House Committee on Oversight and Government Reform have sent letters to seven drugmakers as part of an investigation into why prices for multiple sclerosis drugs have nearly quadrupled since 2004. Reps. Elijah Cummings (D-Md.) and Peter Welch (D-Mass.) penned inquiries to Bayer, Biogen, EMD Serono, Novartis, Roche, Sanofi-Aventis and Teva Pharmaceuticals. Get […]
Missouri judge slashes 86 plaintiffs from Essure suit against Bayer
A federal judge in Missouri cut 86 of the 94 plaintiffs from a group of consolidated lawsuits filed against Bayer (ETR:BAYN) over its Essure female sterilization device. Essure is a small metal coil that’s placed in the fallopian tubes via catheter. The FDA said in 2015 that it received 5,093 complaints in the 13 years since Essure’s approval, including […]
Bayer wins FDA nod for connected MS auto-injector
Bayer (ETR:BAYN) said yesterday that the FDA approved a supplemental biologics license application for the BetaConnect Navigator and myBetaApp – software for its electronic BetaConnect auto-injector. The company’s BetaConnect auto-injector administers Betaseron for patients with relapsing-remitting multiple sclerosis. The newly-approved software allows patients to connect their device with the myBetaApp on their mobile device or computer […]
Critic questions FDA’s handling of Essure product complaints
FDA continues to update how it is informing the public about the controversial Essure permanent birth control device from Bayer. But at least one prominent critic sees holes in FDA’s efforts. “Many women are still being implanted with the device without adequate warnings of the risks associated with the device,” attorney Holly Ennis wrote in an […]
Bayer, Versant close $225m Series A to launch stem cell company
Bayer (ETR:BAYN) and Versant Ventures said today that the 2 groups closed a $225 million Series A financing round to launch BlueRock Therapeutics, a regenerative medicine company focused on developing induced pluripotent stem cell therapies. The funds are estimated to support the company for 4 years as it advances cell therapy clinical programs for cardiovascular and degenerative diseases. “Accessing […]
French women file complaints over complications with Bayer’s Essure
Two French women who’ve used Bayer‘s (ETR:BAYN) controversial Essure contraceptive implant have filed a legal complaint alleging similar side-effects to those filed in the U.S. Essure is a small metal coil that’s placed in the fallopian tubes via catheter. The FDA said last year that in the 13 years since Essure’s approval, the agency had received 5,093 complaints, […]
FDA recommends new label for Bayer’s Essure
The FDA this week released new labeling requirements for Bayer’s (ETR:BAYN) controversial Essure and other permanent hysteroscopically-placed tubal sterilization implants. Essure is a small metal coil that’s placed in the fallopian tubes via catheter. The FDA said last year that in the 13 years since Essure’s approval, the agency had received 5,093 complaints, including for pain or menstrual irregularities […]
Bayer eyes $1B sale of medical skin cream business
(Reuters) — Bayer (ETR:BAYN) has short-listed India’s Lupin (NSE:LUPIN) and investor BC Partners as prospective buyers of medical skin cream assets in a potentially €1 billion ($1.1 billion) deal, several people familiar with the sale told Reuters. Germany’s Bayer has for more than 2 years sought to narrow the focus of its healthcare division and its planned $66 billion Monsanto […]
Misonix CEO steps down | Personnel Moves October 4, 2016
Misonix CEO steps down Misonix (NSDQ:MSON) CEO Michael McManus, Jr. stepped down in early September, also leaving his post as director and chairman of the board of directors. Stavros Vizirgianakis, a member of the board of directors, is serving as the interim CEO while negotiating for a full-time position in the corner office. Vizirgiankis, who owned […]